PARWATI MADDALI: Open Payments
NPI 1669475497 · ROCKLEDGE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,277 in 45 payments from 12 companies in 2025. Trend: 2023 $8,925 · 2024 $2,063 · 2025 $1,277
Food & beverage: $1,168Education: $109
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $214 |
| Vanda Pharmaceuticals Inc. | 10 | $213 |
| Otsuka America Pharmaceutical, Inc. | 5 | $180 |
| Teva Pharmaceuticals USA, Inc. | 7 | $148 |
| E.R. Squibb & Sons, L.L.C. | 1 | $125 |
| ABBVIE INC. | 2 | $116 |
| Axsome Therapeutics, Inc. | 5 | $113 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Neurocrine BioSciences, Inc. | 3 | $57 |
| Almatica Pharma LLC | 1 | $17 |
Products named: CAPLYTA, FANAPT, REXULTI, COBENFY, VRAYLAR, Auvelity, TRINTELLIX, INGREZZA.
Industry payments across FL — which companies pay providers there.
